首页> 外文会议>World Congress on Heart Disease >The use of autologous stem cells CD133 + for regenerative treatment of cardio-vascular diseases.
【24h】

The use of autologous stem cells CD133 + for regenerative treatment of cardio-vascular diseases.

机译:使用自体干细胞CD133 +进行血管疾病的再生治疗。

获取原文

摘要

Objective: To study the safety and effectiveness of transplantation of autolog stem cells CD133, isolated from the bone marrow of the patients.Material and methods: The study included 33 patients: 13 patients (12 male and 1 female, mean age 52 ± 8 years) had ischemic heart disease (IHD), angina of I-III functional class (FC), with a anamnesis the Q-rnyocardial infarction prescription 3 -6 months, post-infarction cardiosclerosis, 8 (4 males and 4 females, mean age 33 ± 8 years) had a liver cirrhosis (LC) and 12 have an obliterative disease of the lower extremities. Bone marrows were taken as standard puncture of the sternum under local anesthesia. Stem cells CD133 (SC-CD133) were isolated by density gradient centrifugation in ficoll, followed by irnmuno-magnetic separation. Autologous isolated cells of patients (5 ml of suspension containing 0,8-L5 million SC-CD133) were used for each patient: in those with coronary artery disease the cells were injected intraar-terially into the coronary arteries under angiography, in patients with liver cirrhosis the cells were injected into the hepatic vein, and in patients with obliterative diseases of the lower extremities, the cells were injected into the common femoral artery. All patients received 0.8mg estradiol/day for two months.Results: After transplantation, in patients with IHD, ejection fraction of left ventricle increased from 50 ± 9% to 58 ± 9% (p <0,001) after 6 months in addition noted the decrease in LV cavity according scintigraphy. Positive dynamic parameters were also observed in patients with obliterative diseases of the lower extremities, the saturation of tissue oxygenation in the affected limb in most patients has improved significantly. The results of cell therapy in patients with LC are still in the process of learning.Conclusion: The procedure for implantation of autologous stem cells CD133,isolated from the bone manow of the patients is safe, has a beneficial effect on the process of rehabilitation treatment of various organs.
机译:目的:研究自闭症干细胞移植的安全性和有效性CD133,从患者骨髓中分离出。材料和方法:该研究包括33例患者:13名患者(12名男性,1名女性,平均52岁52°±8年)缺血性心脏病(IHD),I-III功能级(FC)的心绞痛,厌氧Q-RNYADARDIAL梗死处方3-6个月,梗死后心悸,8名(4名男性和4名女性,平均年龄33 ±8年)肝硬化(LC)和12个具有下肢的灭错疾病。在局部麻醉下被视为胸骨的标准刺穿。通过甲状变物中的密度梯度离心分离干细胞CD133(SC-CD133),然后是Irnmuno-磁性分离。对每只患者使用自体分离的患者(含有0,8-15万SC-CD133)的患者:在冠状动脉疾病的那些中,细胞在血管造影的血管造影术中注射到血管造影下的冠状动脉中。肝硬化细胞注射到肝静脉中,并在下肢的灭错疾病患者中,将细胞注射到共同的股动脉中。所有患者均接受0.8mg雌二醇/日/天。结果:移植后,在IHD患者中,6个月后,左心室的射血分数从50±9%增加到58±9%(P <0.001)根据闪烁形式减少LV腔。在下肢的灭错疾病患者中也观察到阳性动力学参数,大多数患者在大多数患者中受影响的肢体中的组织氧合的饱和度显着提高。 LC患者的细胞疗法的结果仍处于学习过程中。结论:植入自体干细胞CD133的程序,患者骨骼粪便骨骼中分离,对康复治疗过程有益效果各种器官。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号